Finally, the lack of LAIR-1 and CD33 expression on circulating SLE myelomonocytes, along with the frequent abnormalities related to C1q in SLE27, are consistent with the idea that C1q/CD33/LAIR-1 tolerogenic networks are disrupted in SLE. The gene discussed is CD33; the disease is systemic lupus erythematosus.